tiprankstipranks
Genomtec SA (DE:4VI)
FRANKFURT:4VI
Germany Market

Genomtec SA (4VI) Stock Price & Analysis

0 Followers

4VI Stock Chart & Stats

Day’s Range€0 - €0
52-Week Range€1.69 - €3.40
Previous Close€2.21
Volume0.00
Average Volume (3M)560.00
Market Cap
€32.97M
Enterprise Value€32.34M
Total Cash (Recent Filing)zł3.91M
Total Debt (Recent Filing)zł1.21M
Price to Earnings (P/E)
Beta0.72
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-1.45
Shares Outstanding11,395,540
10 Day Avg. Volume0
30 Day Avg. Volume560
Standard DeviationN/A
R-SquaredN/A
AlphaN/A
Financial Highlights & Ratios
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0

Financials

Annual

4VI FAQ

What was Genomtec SA’s price range in the past 12 months?
Genomtec SA lowest stock price was €1.69 and its highest was €3.40 in the past 12 months.
    What is Genomtec SA’s market cap?
    Currently, no data Available
    When is Genomtec SA’s upcoming earnings report date?
    The company’s upcoming earnings report date is not yet available.
    How were Genomtec SA’s earnings last quarter?
    Currently, no data Available
    Is Genomtec SA overvalued?
    According to Wall Street analysts Genomtec SA’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
      Does Genomtec SA pay dividends?
      Genomtec SA does not currently pay dividends.
      What is Genomtec SA’s EPS estimate?
      Genomtec SA’s EPS estimate for its next earnings report is not yet available.
      How many shares outstanding does Genomtec SA have?
      Genomtec SA has 13,324,570 shares outstanding.
        What happened to Genomtec SA’s price movement after its last earnings report?
        Currently, no data Available
        Which hedge fund is a major shareholder of Genomtec SA?
        Currently, no hedge funds are holding shares in DE:4VI
        ---

        Genomtec SA Stock Smart Score

        10
        Unlock Smart Score
        1
        2
        3
        4
        5
        6
        7
        8
        9
        10

        Technicals

        SMA
        Negative
        20 days / 200 days
        Momentum
        13.91%
        12-Months-Change

        Fundamentals

        Return on Equity
        Trailing 12-Months
        Asset Growth
        60.09%
        Trailing 12-Months

        Company Description

        Genomtec SA

        Genomtec SA is an innovative technology company which works in the area of molecular diagnostics. It is a manufacturer of mobile molecular analyzers. The device are designed to identify pathogens including viruses, bacteria, and fungi by amplifying and detecting specific DNA and RNA fragments.
        ---
        Similar Stocks
        Company
        Price & Change
        Follow
        AURELIUS Equity Opportunities SE & Co. KGaA
        Exasol AG
        Popular Stocks
        ---
        What's Included in PREMIUM?
        Make informed decisions based on Top Analysts' activity
        Know what industry insiders are buying
        Get actionable alerts from top Wall Street Analysts
        Find out before anyone else which stock is going to shoot up
        Get powerful stock screeners & detailed portfolio analysis